

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fc-gamma receptor signaling pathway (GO:0038094) | 9.78465813 |
| 2 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 9.78465813 |
| 3 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 9.78465813 |
| 4 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 9.65667105 |
| 5 | cytidine deamination (GO:0009972) | 9.61535995 |
| 6 | cytidine metabolic process (GO:0046087) | 9.61535995 |
| 7 | cytidine catabolic process (GO:0006216) | 9.61535995 |
| 8 | mesoderm development (GO:0007498) | 8.95753969 |
| 9 | mesenchyme development (GO:0060485) | 8.08283313 |
| 10 | humoral immune response (GO:0006959) | 8.05262668 |
| 11 | retina homeostasis (GO:0001895) | 7.94109464 |
| 12 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 7.32220644 |
| 13 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 7.32220644 |
| 14 | gonadal mesoderm development (GO:0007506) | 60.0484789 |
| 15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.94002825 |
| 16 | cellular response to zinc ion (GO:0071294) | 6.15929283 |
| 17 | B cell receptor signaling pathway (GO:0050853) | 6.15112635 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.09129205 |
| 19 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.75970991 |
| 20 | nucleosome assembly (GO:0006334) | 5.57512303 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.45058968 |
| 22 | N-acetylneuraminate metabolic process (GO:0006054) | 5.44919806 |
| 23 | sex differentiation (GO:0007548) | 5.32171252 |
| 24 | negative regulation of glucose import (GO:0046325) | 5.29518588 |
| 25 | negative regulation of B cell proliferation (GO:0030889) | 4.78667410 |
| 26 | protein-DNA complex assembly (GO:0065004) | 4.76930759 |
| 27 | regulation of B cell proliferation (GO:0030888) | 4.64225023 |
| 28 | nucleosome organization (GO:0034728) | 4.52794958 |
| 29 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.31066217 |
| 30 | negative regulation of glucose transport (GO:0010829) | 4.26354432 |
| 31 | regulation of B cell differentiation (GO:0045577) | 4.21124696 |
| 32 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.03906418 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.01998998 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01998998 |
| 35 | protein-DNA complex subunit organization (GO:0071824) | 3.98947149 |
| 36 | signal peptide processing (GO:0006465) | 3.94704400 |
| 37 | B cell proliferation (GO:0042100) | 3.81216288 |
| 38 | regulation of B cell apoptotic process (GO:0002902) | 3.78788066 |
| 39 | immune response-activating signal transduction (GO:0002757) | 3.71879400 |
| 40 | regulation of germinal center formation (GO:0002634) | 3.66492984 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.64362821 |
| 42 | negative regulation of B cell apoptotic process (GO:0002903) | 3.61975382 |
| 43 | negative regulation of gene silencing (GO:0060969) | 3.59126751 |
| 44 | positive regulation of macrophage cytokine production (GO:0060907) | 3.58968550 |
| 45 | somatic diversification of immunoglobulins (GO:0016445) | 3.50069549 |
| 46 | * Fc receptor signaling pathway (GO:0038093) | 3.39509491 |
| 47 | * immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.36337529 |
| 48 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.36063273 |
| 49 | activation of immune response (GO:0002253) | 3.35206783 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32293173 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.25948280 |
| 52 | positive thymic T cell selection (GO:0045059) | 3.23956580 |
| 53 | thymic T cell selection (GO:0045061) | 3.22380819 |
| 54 | positive regulation of immunoglobulin production (GO:0002639) | 3.22355587 |
| 55 | B cell homeostasis (GO:0001782) | 3.21792623 |
| 56 | regulation of B cell activation (GO:0050864) | 3.19010334 |
| 57 | germinal center formation (GO:0002467) | 3.18181331 |
| 58 | B cell activation involved in immune response (GO:0002312) | 3.18085695 |
| 59 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.09641967 |
| 60 | * Fc-epsilon receptor signaling pathway (GO:0038095) | 3.09043326 |
| 61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07565763 |
| 62 | proline biosynthetic process (GO:0006561) | 3.07261184 |
| 63 | positive regulation of B cell proliferation (GO:0030890) | 3.02473633 |
| 64 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.01483731 |
| 65 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.01483731 |
| 66 | isotype switching (GO:0045190) | 3.01483731 |
| 67 | complement activation, classical pathway (GO:0006958) | 21.6815004 |
| 68 | somatic diversification of immune receptors (GO:0002200) | 2.99702236 |
| 69 | negative T cell selection (GO:0043383) | 2.98434346 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.98151031 |
| 71 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.96833682 |
| 72 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.96833682 |
| 73 | phenylpropanoid metabolic process (GO:0009698) | 2.96752699 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.96274939 |
| 75 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96068247 |
| 76 | mature B cell differentiation (GO:0002335) | 2.95832317 |
| 77 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.95471906 |
| 78 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.93912727 |
| 79 | regulation of chromatin silencing (GO:0031935) | 2.93336913 |
| 80 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.92074668 |
| 81 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.86889986 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.86846782 |
| 83 | DNA strand elongation (GO:0022616) | 2.81024697 |
| 84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77985291 |
| 85 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.75787001 |
| 86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75773662 |
| 87 | B cell activation (GO:0042113) | 2.74559369 |
| 88 | negative regulation of B cell activation (GO:0050869) | 2.74177568 |
| 89 | DNA demethylation (GO:0080111) | 2.73600601 |
| 90 | regulation of activation of Janus kinase activity (GO:0010533) | 2.70319150 |
| 91 | T cell selection (GO:0045058) | 2.66331648 |
| 92 | mast cell activation (GO:0045576) | 2.65484741 |
| 93 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.64642032 |
| 94 | positive regulation of B cell activation (GO:0050871) | 2.63059526 |
| 95 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61760966 |
| 96 | positive regulation of protein homooligomerization (GO:0032464) | 2.60582396 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 2.58631387 |
| 98 | ribosomal small subunit biogenesis (GO:0042274) | 2.57852097 |
| 99 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57632501 |
| 100 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57359957 |
| 101 | mitotic chromosome condensation (GO:0007076) | 2.56021703 |
| 102 | regulation of immunoglobulin production (GO:0002637) | 2.53928197 |
| 103 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.52738537 |
| 104 | positive regulation of Rap GTPase activity (GO:0032854) | 2.52191946 |
| 105 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.51401640 |
| 106 | lymphocyte homeostasis (GO:0002260) | 2.50782387 |
| 107 | regulation of acrosome reaction (GO:0060046) | 2.49875185 |
| 108 | ribosomal small subunit assembly (GO:0000028) | 2.48592224 |
| 109 | respiratory burst (GO:0045730) | 2.47935977 |
| 110 | regulation of macrophage cytokine production (GO:0010935) | 2.47429240 |
| 111 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.45916934 |
| 112 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.45698472 |
| 113 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.43665349 |
| 114 | negative regulation of B cell mediated immunity (GO:0002713) | 2.41768088 |
| 115 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.41768088 |
| 116 | apoptotic cell clearance (GO:0043277) | 2.41323090 |
| 117 | protein targeting to ER (GO:0045047) | 2.40598979 |
| 118 | regulation of female gonad development (GO:2000194) | 2.29081370 |
| 119 | regulation of chromatin binding (GO:0035561) | 2.27271914 |
| 120 | positive regulation of viral genome replication (GO:0045070) | 2.10401112 |
| 121 | multicellular organism reproduction (GO:0032504) | 2.05304496 |
| 122 | sialylation (GO:0097503) | 2.04075917 |
| 123 | amyloid precursor protein catabolic process (GO:0042987) | 2.01652303 |
| 124 | positive regulation of isotype switching (GO:0045830) | 2.01153873 |
| 125 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.00633177 |
| 126 | complement activation (GO:0006956) | 16.5875606 |
| 127 | protein activation cascade (GO:0072376) | 10.7496321 |
| 128 | amyloid precursor protein metabolic process (GO:0042982) | 1.97798144 |
| 129 | oocyte development (GO:0048599) | 1.94438642 |
| 130 | protein K63-linked deubiquitination (GO:0070536) | 1.93285952 |
| 131 | negative regulation of Notch signaling pathway (GO:0045746) | 1.92685413 |
| 132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 1.91667808 |
| 133 | protein K48-linked deubiquitination (GO:0071108) | 1.90420453 |
| 134 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.89773010 |
| 135 | cellular response to interleukin-6 (GO:0071354) | 1.86676791 |
| 136 | spermatogenesis (GO:0007283) | 1.86533063 |
| 137 | male gamete generation (GO:0048232) | 1.85743688 |
| 138 | mitotic metaphase plate congression (GO:0007080) | 1.84162708 |
| 139 | COPI coating of Golgi vesicle (GO:0048205) | 1.79739338 |
| 140 | Golgi transport vesicle coating (GO:0048200) | 1.79739338 |
| 141 | reproductive structure development (GO:0048608) | 1.78970776 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 1.77661639 |
| 143 | regulation of cell maturation (GO:1903429) | 1.74017015 |
| 144 | gamete generation (GO:0007276) | 1.73951679 |
| 145 | binding of sperm to zona pellucida (GO:0007339) | 1.73026690 |
| 146 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 1.72644376 |
| 147 | positive regulation of DNA recombination (GO:0045911) | 1.69736846 |
| 148 | ganglioside metabolic process (GO:0001573) | 1.68383291 |
| 149 | viral transcription (GO:0019083) | 1.66943852 |
| 150 | cellular sodium ion homeostasis (GO:0006883) | 1.65998810 |
| 151 | translational termination (GO:0006415) | 1.63245790 |
| 152 | protein localization to endoplasmic reticulum (GO:0070972) | 1.63090534 |
| 153 | oligosaccharide catabolic process (GO:0009313) | 1.62812404 |
| 154 | positive regulation of humoral immune response (GO:0002922) | 1.62175443 |
| 155 | regulation of DNA methylation (GO:0044030) | 1.61546440 |
| 156 | neutrophil mediated immunity (GO:0002446) | 1.60884758 |
| 157 | autophagic vacuole fusion (GO:0000046) | 1.60103948 |
| 158 | ER overload response (GO:0006983) | 1.58485595 |
| 159 | cotranslational protein targeting to membrane (GO:0006613) | 1.58251144 |
| 160 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 1.57432563 |
| 161 | translational elongation (GO:0006414) | 1.55056325 |
| 162 | protein kinase C signaling (GO:0070528) | 1.53621135 |
| 163 | mitotic nuclear envelope disassembly (GO:0007077) | 1.53607364 |
| 164 | regulation of translational fidelity (GO:0006450) | 1.53373542 |
| 165 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 1.53338810 |
| 166 | labyrinthine layer development (GO:0060711) | 1.52385442 |
| 167 | formation of translation preinitiation complex (GO:0001731) | 1.50562168 |
| 168 | stress granule assembly (GO:0034063) | 1.49147388 |
| 169 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.48153409 |
| 170 | meiotic cell cycle (GO:0051321) | 1.48035422 |
| 171 | regulation of penile erection (GO:0060405) | 1.47984589 |
| 172 | organ or tissue specific immune response (GO:0002251) | 1.47904187 |
| 173 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 1.47394521 |
| 174 | modulation by virus of host process (GO:0019054) | 1.46653828 |
| 175 | sodium ion homeostasis (GO:0055078) | 1.46154217 |
| 176 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 1.43311429 |
| 177 | nuclear envelope disassembly (GO:0051081) | 1.42470684 |
| 178 | membrane disassembly (GO:0030397) | 1.42470684 |
| 179 | regulation of mitochondrial membrane permeability (GO:0046902) | 1.42376876 |
| 180 | negative regulation of reproductive process (GO:2000242) | 1.42257390 |
| 181 | response to interleukin-6 (GO:0070741) | 1.42187981 |
| 182 | organelle membrane fusion (GO:0090174) | 1.41422975 |
| 183 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 1.40851087 |
| 184 | N-terminal protein amino acid acetylation (GO:0006474) | 1.40650369 |
| 185 | negative regulation of execution phase of apoptosis (GO:1900118) | 1.39573493 |
| 186 | membrane protein intracellular domain proteolysis (GO:0031293) | 1.38162472 |
| 187 | protein N-linked glycosylation via asparagine (GO:0018279) | 1.37889773 |
| 188 | reproduction (GO:0000003) | 1.37591120 |
| 189 | deoxyribonucleotide biosynthetic process (GO:0009263) | 1.37290987 |
| 190 | amino sugar metabolic process (GO:0006040) | 1.36951311 |
| 191 | regulation of nuclease activity (GO:0032069) | 1.36756098 |
| 192 | peptidyl-asparagine modification (GO:0018196) | 1.36643594 |
| 193 | viral life cycle (GO:0019058) | 1.36556368 |
| 194 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 1.35964622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.51371509 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.07315676 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.49056066 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.21141983 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.70332953 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 4.55617601 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.93041387 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81932333 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.30391857 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20710513 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.14051052 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.08232997 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.92389826 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90272740 |
| 15 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.79710496 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77055732 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.74125940 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63006658 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62206293 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.52779014 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.50900003 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.50891992 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.47754930 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46193729 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32461341 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.31996528 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.26545014 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.24402745 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 2.20665553 |
| 30 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 2.13973292 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.09983370 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08648745 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07936974 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00442998 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.92263804 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.91433695 |
| 37 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.90868540 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90033595 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.86496504 |
| 40 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.84906542 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84161050 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83016189 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82979560 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82062781 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80253866 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79453389 |
| 47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.79388611 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78814532 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76128012 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75730065 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.73014276 |
| 52 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70983636 |
| 53 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.70754610 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69036710 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65679779 |
| 56 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.65213649 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63639535 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.63610578 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.63420517 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.63019188 |
| 61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.62697322 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.62568569 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.61069430 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59673330 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.54570506 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54354724 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54151428 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52042693 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51337133 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49490057 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48199561 |
| 72 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.47712195 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.45297852 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43989391 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42983892 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.42661316 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42635805 |
| 78 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.41984803 |
| 79 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.38938347 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38689437 |
| 81 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36451978 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31347068 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30149177 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29044467 |
| 85 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28328822 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28191167 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28138559 |
| 88 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26989295 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26942711 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25941765 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25735778 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25141497 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25027003 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20934601 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20213232 |
| 96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19730129 |
| 97 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18684645 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17905272 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17483793 |
| 100 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10590275 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09741862 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09625929 |
| 103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08401661 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07584805 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06615676 |
| 106 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.06557699 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05917157 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04607715 |
| 109 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04579288 |
| 110 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02885166 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02183718 |
| 112 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00338910 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99733628 |
| 114 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99469429 |
| 115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99420479 |
| 116 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98690992 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98371596 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97772980 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97358106 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97275253 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97175948 |
| 122 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96549226 |
| 123 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95893590 |
| 124 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95619222 |
| 125 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95139303 |
| 126 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95034070 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.94616667 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94404910 |
| 129 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94142937 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94135150 |
| 131 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93300089 |
| 132 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91877614 |
| 133 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91703773 |
| 134 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.90023520 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88537117 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87467279 |
| 137 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.86607636 |
| 138 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85865332 |
| 139 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85492761 |
| 140 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.84927486 |
| 141 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83544581 |
| 142 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82482275 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80742237 |
| 144 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80183447 |
| 145 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79880933 |
| 146 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.79874570 |
| 147 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79778471 |
| 148 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.78783786 |
| 149 | P300_27268052_Chip-Seq_Bcells_Human | 0.78002840 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77711695 |
| 151 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.77605235 |
| 152 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76572772 |
| 153 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.76147869 |
| 154 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.75156701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.84381972 |
| 2 | MP0001800_abnormal_humoral_immune | 5.32464632 |
| 3 | MP0003136_yellow_coat_color | 4.69848063 |
| 4 | MP0003303_peritoneal_inflammation | 4.46508253 |
| 5 | MP0001790_abnormal_immune_system | 4.17097201 |
| 6 | MP0005387_immune_system_phenotype | 4.17097201 |
| 7 | MP0005671_abnormal_response_to | 3.89628397 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.76063745 |
| 9 | MP0003718_maternal_effect | 3.54056922 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.51378069 |
| 11 | MP0000685_abnormal_immune_system | 3.27456129 |
| 12 | MP0002723_abnormal_immune_serum | 3.23636850 |
| 13 | MP0009840_abnormal_foam_cell | 3.02211291 |
| 14 | MP0002420_abnormal_adaptive_immunity | 3.00721710 |
| 15 | MP0001819_abnormal_immune_cell | 2.92734729 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.92192151 |
| 17 | MP0002398_abnormal_bone_marrow | 2.85852617 |
| 18 | MP0005171_absent_coat_pigmentation | 2.69350172 |
| 19 | MP0000716_abnormal_immune_system | 2.69254124 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.57985467 |
| 21 | MP0003111_abnormal_nucleus_morphology | 2.52874177 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.50184727 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.45695330 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.35454354 |
| 25 | MP0005395_other_phenotype | 2.32720864 |
| 26 | MP0002429_abnormal_blood_cell | 2.20453994 |
| 27 | MP0005025_abnormal_response_to | 2.13227238 |
| 28 | MP0002722_abnormal_immune_system | 2.03777753 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.98112461 |
| 30 | MP0010307_abnormal_tumor_latency | 1.91878012 |
| 31 | MP0001853_heart_inflammation | 1.87471175 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.86426548 |
| 33 | MP0004947_skin_inflammation | 1.85003282 |
| 34 | MP0008057_abnormal_DNA_replication | 1.81993453 |
| 35 | MP0004510_myositis | 1.79703939 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.78895369 |
| 37 | MP0002419_abnormal_innate_immunity | 1.78657733 |
| 38 | MP0002006_tumorigenesis | 1.78144970 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.73641862 |
| 40 | MP0006054_spinal_hemorrhage | 1.71173534 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.66054852 |
| 42 | MP0004043_abnormal_pH_regulation | 1.62314996 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.61492112 |
| 44 | MP0002405_respiratory_system_inflammati | 1.58433557 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.53183535 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.53086890 |
| 47 | MP0003436_decreased_susceptibility_to | 1.49520354 |
| 48 | MP0005310_abnormal_salivary_gland | 1.49164987 |
| 49 | MP0008058_abnormal_DNA_repair | 1.45952637 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.45385816 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.42733594 |
| 52 | MP0002933_joint_inflammation | 1.41349265 |
| 53 | MP0009785_altered_susceptibility_to | 1.39420864 |
| 54 | MP0002090_abnormal_vision | 1.38251206 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.36704022 |
| 56 | MP0008932_abnormal_embryonic_tissue | 1.36611823 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.36241492 |
| 58 | MP0001929_abnormal_gametogenesis | 1.34181920 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.32435378 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.27216366 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.25328771 |
| 62 | MP0003866_abnormal_defecation | 1.24905906 |
| 63 | MP0003699_abnormal_female_reproductive | 1.21380759 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.21294686 |
| 65 | MP0001879_abnormal_lymphatic_vessel | 1.20752025 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.20585450 |
| 67 | MP0003693_abnormal_embryo_hatching | 1.15768007 |
| 68 | MP0000747_muscle_weakness | 1.14032831 |
| 69 | MP0008995_early_reproductive_senescence | 1.13953948 |
| 70 | MP0005360_urolithiasis | 1.11526123 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.09850568 |
| 72 | MP0002210_abnormal_sex_determination | 1.09402352 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 1.07764813 |
| 74 | MP0002136_abnormal_kidney_physiology | 1.07038615 |
| 75 | MP0004957_abnormal_blastocyst_morpholog | 1.04954203 |
| 76 | MP0003868_abnormal_feces_composition | 1.04387611 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.04384451 |
| 78 | MP0000313_abnormal_cell_death | 1.03417648 |
| 79 | MP0005394_taste/olfaction_phenotype | 1.02476858 |
| 80 | MP0005499_abnormal_olfactory_system | 1.02476858 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.01996141 |
| 82 | MP0003786_premature_aging | 1.01195632 |
| 83 | MP0005408_hypopigmentation | 0.98452230 |
| 84 | MP0000490_abnormal_crypts_of | 0.97993766 |
| 85 | MP0001191_abnormal_skin_condition | 0.94661059 |
| 86 | MP0005381_digestive/alimentary_phenotyp | 0.92784596 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.91589749 |
| 88 | MP0002751_abnormal_autonomic_nervous | 0.91372629 |
| 89 | MP0001666_abnormal_nutrient_absorption | 0.90575372 |
| 90 | MP0006082_CNS_inflammation | 0.90370613 |
| 91 | MP0002161_abnormal_fertility/fecundity | 0.89984842 |
| 92 | MP0000653_abnormal_sex_gland | 0.89440878 |
| 93 | MP0001324_abnormal_eye_pigmentation | 0.88390803 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86722441 |
| 95 | MP0005389_reproductive_system_phenotype | 0.86614481 |
| 96 | MP0003045_fibrosis | 0.85103885 |
| 97 | MP0001661_extended_life_span | 0.85052787 |
| 98 | MP0002080_prenatal_lethality | 0.84752621 |
| 99 | MP0005621_abnormal_cell_physiology | 0.84385790 |
| 100 | MP0001145_abnormal_male_reproductive | 0.82488444 |
| 101 | MP0005384_cellular_phenotype | 0.81922906 |
| 102 | MP0008469_abnormal_protein_level | 0.81641126 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.78768368 |
| 104 | MP0003077_abnormal_cell_cycle | 0.78510490 |
| 105 | MP0001119_abnormal_female_reproductive | 0.76356973 |
| 106 | MP0005410_abnormal_fertilization | 0.74603467 |
| 107 | MP0003959_abnormal_lean_body | 0.73102891 |
| 108 | MP0000358_abnormal_cell_content/ | 0.71802323 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.71724750 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.71182674 |
| 111 | MP0001730_embryonic_growth_arrest | 0.70707443 |
| 112 | MP0001697_abnormal_embryo_size | 0.70573041 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.69901996 |
| 114 | MP0005085_abnormal_gallbladder_physiolo | 0.68571607 |
| 115 | MP0001919_abnormal_reproductive_system | 0.67988501 |
| 116 | MP0001186_pigmentation_phenotype | 0.67778686 |
| 117 | MP0000609_abnormal_liver_physiology | 0.66769927 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.66083880 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.66083880 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.65991512 |
| 121 | MP0003698_abnormal_male_reproductive | 0.65716319 |
| 122 | MP0000920_abnormal_myelination | 0.65630605 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.65060081 |
| 124 | MP0006035_abnormal_mitochondrial_morpho | 0.64461379 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.64046292 |
| 126 | MP0002083_premature_death | 0.63536284 |
| 127 | MP0002075_abnormal_coat/hair_pigmentati | 0.62072584 |
| 128 | MP0008569_lethality_at_weaning | 0.61489498 |
| 129 | MP0001664_abnormal_digestion | 0.60596399 |
| 130 | MP0001663_abnormal_digestive_system | 0.59382603 |
| 131 | MP0004808_abnormal_hematopoietic_stem | 0.59105507 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.59090859 |
| 133 | MP0005023_abnormal_wound_healing | 0.58343870 |
| 134 | MP0002796_impaired_skin_barrier | 0.57898968 |
| 135 | MP0003075_altered_response_to | 0.57886110 |
| 136 | MP0002169_no_abnormal_phenotype | 0.56633915 |
| 137 | MP0002873_normal_phenotype | 0.56368391 |
| 138 | MP0002009_preneoplasia | 0.55761905 |
| 139 | MP0008875_abnormal_xenobiotic_pharmacok | 0.54717177 |
| 140 | MP0009763_increased_sensitivity_to | 0.53822988 |
| 141 | MP0001873_stomach_inflammation | 0.51353175 |
| 142 | MP0003828_pulmonary_edema | 0.50658093 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.50096161 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.48758409 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.48283161 |
| 146 | MP0009931_abnormal_skin_appearance | 0.47933135 |
| 147 | MP0005332_abnormal_amino_acid | 0.47183142 |
| 148 | MP0004134_abnormal_chest_morphology | 0.44128087 |
| 149 | MP0000350_abnormal_cell_proliferation | 0.43082623 |
| 150 | MP0005388_respiratory_system_phenotype | 0.39231752 |
| 151 | MP0002133_abnormal_respiratory_system | 0.39231752 |
| 152 | MP0005451_abnormal_body_composition | 0.38111144 |
| 153 | MP0003656_abnormal_erythrocyte_physiolo | 0.37765603 |
| 154 | MP0008874_decreased_physiological_sensi | 0.37613271 |
| 155 | MP0002168_other_aberrant_phenotype | 0.36142755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.12481573 |
| 2 | Recurrent sinusitis (HP:0011108) | 7.08335983 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 6.90251062 |
| 4 | Recurrent bronchitis (HP:0002837) | 6.59274202 |
| 5 | Abnormality of B cell number (HP:0010975) | 6.27851326 |
| 6 | B lymphocytopenia (HP:0010976) | 6.27851326 |
| 7 | Cellulitis (HP:0100658) | 5.96399192 |
| 8 | IgM deficiency (HP:0002850) | 5.83123159 |
| 9 | Papilloma (HP:0012740) | 5.47044853 |
| 10 | Verrucae (HP:0200043) | 5.47044853 |
| 11 | Colitis (HP:0002583) | 5.40030774 |
| 12 | Recurrent lower respiratory tract infections (HP:0002783) | 5.14997720 |
| 13 | Recurrent pneumonia (HP:0006532) | 5.05992557 |
| 14 | Chronic sinusitis (HP:0011109) | 4.88046813 |
| 15 | Meningitis (HP:0001287) | 4.78479871 |
| 16 | IgG deficiency (HP:0004315) | 4.77111418 |
| 17 | Recurrent viral infections (HP:0004429) | 4.70233966 |
| 18 | IgA deficiency (HP:0002720) | 4.62907839 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 4.62210066 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 4.57778400 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 4.55968356 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.55968356 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.55968356 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.53174304 |
| 25 | Chronic otitis media (HP:0000389) | 4.45370755 |
| 26 | Inflammation of the large intestine (HP:0002037) | 4.38908446 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 4.23260616 |
| 28 | Carpal bone hypoplasia (HP:0001498) | 4.21031095 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 4.15755651 |
| 30 | Decreased circulating renin level (HP:0003351) | 4.15039875 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 4.07887153 |
| 32 | Emphysema (HP:0002097) | 4.07527077 |
| 33 | Thyroiditis (HP:0100646) | 3.93637771 |
| 34 | Lymphopenia (HP:0001888) | 3.88652025 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.87221673 |
| 36 | Albinism (HP:0001022) | 3.83434180 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.81954718 |
| 38 | Large for gestational age (HP:0001520) | 3.81950595 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.71549830 |
| 40 | Overlapping toe (HP:0001845) | 3.69218009 |
| 41 | Bronchitis (HP:0012387) | 3.68691052 |
| 42 | Vasculitis (HP:0002633) | 3.67571793 |
| 43 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.67016320 |
| 44 | Osteomyelitis (HP:0002754) | 3.61981800 |
| 45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.59581451 |
| 46 | Abnormal tarsal ossification (HP:0008369) | 3.56632493 |
| 47 | Dysostosis multiplex (HP:0000943) | 3.46259419 |
| 48 | Sepsis (HP:0100806) | 3.45366341 |
| 49 | Recurrent otitis media (HP:0000403) | 3.42615793 |
| 50 | Spinal cord lesions (HP:0100561) | 3.19982755 |
| 51 | Syringomyelia (HP:0003396) | 3.19982755 |
| 52 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.18932403 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.17633916 |
| 54 | Abnormality of T cells (HP:0002843) | 3.14128672 |
| 55 | Deep palmar crease (HP:0006191) | 3.12868168 |
| 56 | Hypercortisolism (HP:0001578) | 3.12587037 |
| 57 | Vertebral compression fractures (HP:0002953) | 3.05005388 |
| 58 | Restrictive lung disease (HP:0002091) | 3.04509568 |
| 59 | Ankyloglossia (HP:0010296) | 3.04383233 |
| 60 | Lower limb hyperreflexia (HP:0002395) | 3.04036620 |
| 61 | Tetraparesis (HP:0002273) | 3.01061339 |
| 62 | Patchy hypopigmentation of hair (HP:0011365) | 3.00116242 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.97106279 |
| 64 | Skin rash (HP:0000988) | 2.93910023 |
| 65 | Abnormality of incisor morphology (HP:0011063) | 2.92864539 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.89348702 |
| 67 | Hypokinesia (HP:0002375) | 2.88347711 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.86733947 |
| 69 | Long palpebral fissure (HP:0000637) | 2.85000421 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80339375 |
| 71 | Abnormal auditory evoked potentials (HP:0006958) | 2.78611734 |
| 72 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.78244732 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.74934278 |
| 74 | Reticulocytopenia (HP:0001896) | 2.72343729 |
| 75 | Dry hair (HP:0011359) | 2.70487403 |
| 76 | Microretrognathia (HP:0000308) | 2.68626560 |
| 77 | Ridged nail (HP:0001807) | 2.61011438 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.56109031 |
| 79 | Recurrent abscess formation (HP:0002722) | 2.51960975 |
| 80 | Xerostomia (HP:0000217) | 2.51460163 |
| 81 | Recurrent bacterial skin infections (HP:0005406) | 2.49764439 |
| 82 | Exocrine pancreatic insufficiency (HP:0001738) | 2.48255203 |
| 83 | T lymphocytopenia (HP:0005403) | 2.46246266 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.45667971 |
| 85 | Hyperkalemia (HP:0002153) | 2.44446815 |
| 86 | Abnormal foot bone ossification (HP:0010675) | 2.43806483 |
| 87 | Leukopenia (HP:0001882) | 2.43548467 |
| 88 | Severe combined immunodeficiency (HP:0004430) | 2.41121933 |
| 89 | Thoracolumbar scoliosis (HP:0002944) | 2.40242144 |
| 90 | Loss of speech (HP:0002371) | 2.38006709 |
| 91 | Apathy (HP:0000741) | 2.35971387 |
| 92 | Lymphoma (HP:0002665) | 2.35809771 |
| 93 | Adrenal overactivity (HP:0002717) | 2.34432331 |
| 94 | Mitral stenosis (HP:0001718) | 2.34252131 |
| 95 | Recurrent skin infections (HP:0001581) | 2.29160843 |
| 96 | Unilateral renal agenesis (HP:0000122) | 2.29070368 |
| 97 | Eosinophilia (HP:0001880) | 2.28817944 |
| 98 | Abnormality of oral frenula (HP:0000190) | 2.28260912 |
| 99 | Skin ulcer (HP:0200042) | 2.27890362 |
| 100 | Diminished motivation (HP:0000745) | 2.26122789 |
| 101 | Spastic paraparesis (HP:0002313) | 2.26110910 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25253465 |
| 103 | Chronic bronchitis (HP:0004469) | 2.23276952 |
| 104 | Conical tooth (HP:0000698) | 2.22863928 |
| 105 | Onycholysis (HP:0001806) | 2.22170768 |
| 106 | Hypokalemic alkalosis (HP:0001949) | 2.19479105 |
| 107 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.19477037 |
| 108 | Abnormal protein glycosylation (HP:0012346) | 2.19409730 |
| 109 | Abnormal glycosylation (HP:0012345) | 2.19409730 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19409730 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19409730 |
| 112 | Deformed sella turcica (HP:0002681) | 2.17432444 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15953903 |
| 114 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15953903 |
| 115 | Nasal polyposis (HP:0100582) | 2.14334873 |
| 116 | White forelock (HP:0002211) | 2.13233744 |
| 117 | Hypertensive crisis (HP:0100735) | 2.13139795 |
| 118 | Upper limb muscle weakness (HP:0003484) | 2.11741165 |
| 119 | Papilledema (HP:0001085) | 2.11062290 |
| 120 | Abnormality of the lumbar spine (HP:0100712) | 2.11005839 |
| 121 | Exercise-induced myalgia (HP:0003738) | 2.10416785 |
| 122 | Acrocyanosis (HP:0001063) | 2.08769284 |
| 123 | Eczematoid dermatitis (HP:0000976) | 2.07968531 |
| 124 | Viral hepatitis (HP:0006562) | 2.06398656 |
| 125 | Short middle phalanx of the 5th finger (HP:0004220) | 2.05711135 |
| 126 | Thoracic kyphosis (HP:0002942) | 2.04723057 |
| 127 | Arthralgia (HP:0002829) | 2.02629347 |
| 128 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.02585130 |
| 129 | Mucosal telangiectasiae (HP:0100579) | 2.02581487 |
| 130 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02283881 |
| 131 | Self-mutilation (HP:0000742) | 2.02273046 |
| 132 | Hyponatremia (HP:0002902) | 2.01928648 |
| 133 | Abnormality of macrophages (HP:0004311) | 2.01333135 |
| 134 | Dysmetric saccades (HP:0000641) | 2.00904376 |
| 135 | Abnormality of the thoracic spine (HP:0100711) | 2.00725439 |
| 136 | Type I transferrin isoform profile (HP:0003642) | 2.00234572 |
| 137 | Impulsivity (HP:0100710) | 1.99582980 |
| 138 | Neutropenia (HP:0001875) | 1.99106423 |
| 139 | Facial hemangioma (HP:0000329) | 1.98527763 |
| 140 | Small epiphyses (HP:0010585) | 1.97864057 |
| 141 | Long eyelashes (HP:0000527) | 1.97351986 |
| 142 | Thrombocytosis (HP:0001894) | 1.97171094 |
| 143 | Abnormal number of erythroid precursors (HP:0012131) | 1.96586140 |
| 144 | Limb hypertonia (HP:0002509) | 1.95462862 |
| 145 | Encephalitis (HP:0002383) | 1.95370194 |
| 146 | Pulmonary infiltrates (HP:0002113) | 1.94456190 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.93974094 |
| 148 | Hyperlipoproteinemia (HP:0010980) | 1.93577952 |
| 149 | Abnormal pupillary function (HP:0007686) | 1.93554689 |
| 150 | Obstructive lung disease (HP:0006536) | 1.90326947 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.90326947 |
| 152 | Visual hallucinations (HP:0002367) | 1.88737194 |
| 153 | Hypoplasia of the thymus (HP:0000778) | 1.88654663 |
| 154 | Increased IgE level (HP:0003212) | 1.87542525 |
| 155 | Acute hepatic failure (HP:0006554) | 1.85965429 |
| 156 | Progressive visual loss (HP:0000529) | 1.85361620 |
| 157 | Chromsome breakage (HP:0040012) | 1.85014577 |
| 158 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84814866 |
| 159 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84814866 |
| 160 | Myositis (HP:0100614) | 1.84275212 |
| 161 | Abnormality of the nasal mucosa (HP:0000433) | 1.84193764 |
| 162 | Asymmetry of the thorax (HP:0001555) | 1.84138016 |
| 163 | Urethral obstruction (HP:0000796) | 1.82514685 |
| 164 | Oligodactyly (HP:0012165) | 1.81769959 |
| 165 | Abnormality of the columella (HP:0009929) | 1.81681199 |
| 166 | Hypergammaglobulinemia (HP:0010702) | 1.81149593 |
| 167 | Hypergonadotropic hypogonadism (HP:0000815) | 1.79688663 |
| 168 | Pustule (HP:0200039) | 1.79361154 |
| 169 | Generalized hypopigmentation (HP:0007513) | 1.77791964 |
| 170 | Anterior segment dysgenesis (HP:0007700) | 1.77285488 |
| 171 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.76071986 |
| 172 | Granulocytopenia (HP:0001913) | 1.74017837 |
| 173 | Autoimmune hemolytic anemia (HP:0001890) | 1.71361756 |
| 174 | Colon cancer (HP:0003003) | 1.70697674 |
| 175 | Erythema (HP:0010783) | 1.69262142 |
| 176 | Urticaria (HP:0001025) | 1.67595114 |
| 177 | Keratoconjunctivitis sicca (HP:0001097) | 1.66249217 |
| 178 | Abnormality of eosinophils (HP:0001879) | 1.65225378 |
| 179 | Teleangiectasia of the skin (HP:0100585) | 1.65151366 |
| 180 | Conjunctival hamartoma (HP:0100780) | 1.62727142 |
| 181 | Squamous cell carcinoma (HP:0002860) | 1.62129142 |
| 182 | Basal cell carcinoma (HP:0002671) | 1.59180951 |
| 183 | Leukocytosis (HP:0001974) | 1.58385313 |
| 184 | Paralysis (HP:0003470) | 1.55075758 |
| 185 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.54541042 |
| 186 | Dehydration (HP:0001944) | 1.54342609 |
| 187 | Deep venous thrombosis (HP:0002625) | 1.51257440 |
| 188 | Spontaneous hematomas (HP:0007420) | 1.50576248 |
| 189 | Bronchiectasis (HP:0002110) | 1.48344200 |
| 190 | Cutaneous melanoma (HP:0012056) | 1.47835767 |
| 191 | Keratoconjunctivitis (HP:0001096) | 1.47403669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.31113488 |
| 2 | PRPF4B | 6.15833995 |
| 3 | ARAF | 4.37336264 |
| 4 | ERN1 | 3.99123647 |
| 5 | BLK | 3.76880789 |
| 6 | BRAF | 3.30006188 |
| 7 | RIPK4 | 3.17279960 |
| 8 | SYK | 3.13918179 |
| 9 | CSF1R | 3.08776103 |
| 10 | TAOK2 | 2.94063067 |
| 11 | PRKCH | 2.80233369 |
| 12 | TESK2 | 2.54953007 |
| 13 | GRK6 | 2.44448063 |
| 14 | BUB1 | 2.30266438 |
| 15 | BTK | 2.06778185 |
| 16 | CDK19 | 1.99306230 |
| 17 | LYN | 1.98277474 |
| 18 | MAP3K14 | 1.92660375 |
| 19 | MST4 | 1.85920229 |
| 20 | MAP3K13 | 1.83604725 |
| 21 | KIT | 1.83566347 |
| 22 | TAF1 | 1.83115794 |
| 23 | PRKCQ | 1.75499778 |
| 24 | RAF1 | 1.71935513 |
| 25 | NEK2 | 1.67550437 |
| 26 | STK10 | 1.65727893 |
| 27 | PRKCI | 1.59067248 |
| 28 | TBK1 | 1.58969135 |
| 29 | MOS | 1.47447445 |
| 30 | MAP3K10 | 1.46254396 |
| 31 | ITK | 1.44566500 |
| 32 | SCYL2 | 1.43193711 |
| 33 | EIF2AK3 | 1.43116390 |
| 34 | KSR1 | 1.42201957 |
| 35 | CLK1 | 1.41865078 |
| 36 | LRRK2 | 1.41706302 |
| 37 | TTK | 1.40575518 |
| 38 | SIK2 | 1.38135625 |
| 39 | TYK2 | 1.34605520 |
| 40 | FES | 1.34504391 |
| 41 | ICK | 1.34377707 |
| 42 | IRAK4 | 1.34203596 |
| 43 | CDK3 | 1.33324184 |
| 44 | MAPK7 | 1.28521845 |
| 45 | CDK8 | 1.21609789 |
| 46 | HCK | 1.19098274 |
| 47 | ALK | 1.16221300 |
| 48 | FGFR3 | 1.09085752 |
| 49 | NME2 | 1.07414898 |
| 50 | STK16 | 1.06448787 |
| 51 | JAK3 | 0.99950078 |
| 52 | JAK1 | 0.99211659 |
| 53 | LCK | 0.97474457 |
| 54 | MAP3K1 | 0.97460109 |
| 55 | AURKA | 0.92984322 |
| 56 | CDC42BPA | 0.92940403 |
| 57 | FGFR4 | 0.92460833 |
| 58 | IKBKB | 0.91102391 |
| 59 | MAP3K9 | 0.89503829 |
| 60 | BCKDK | 0.88667574 |
| 61 | RPS6KA4 | 0.88467303 |
| 62 | AKT2 | 0.88132761 |
| 63 | EIF2AK1 | 0.86072686 |
| 64 | PDPK1 | 0.85384472 |
| 65 | CSK | 0.85246126 |
| 66 | SRPK1 | 0.84497487 |
| 67 | TAOK3 | 0.83691131 |
| 68 | MATK | 0.83046003 |
| 69 | BRSK1 | 0.82737585 |
| 70 | FGFR2 | 0.82383126 |
| 71 | CDK7 | 0.80908096 |
| 72 | CSNK1G3 | 0.80725639 |
| 73 | CSNK1A1L | 0.80629034 |
| 74 | MELK | 0.80330447 |
| 75 | TRIB3 | 0.79248042 |
| 76 | TEC | 0.78433521 |
| 77 | CDC7 | 0.78187597 |
| 78 | FRK | 0.76785058 |
| 79 | SIK1 | 0.76151435 |
| 80 | IRAK2 | 0.74491621 |
| 81 | IRAK3 | 0.73765289 |
| 82 | PRKCD | 0.70509713 |
| 83 | HIPK2 | 0.68879130 |
| 84 | TGFBR2 | 0.68348021 |
| 85 | CHEK1 | 0.66572612 |
| 86 | PIK3CG | 0.66345451 |
| 87 | CDK9 | 0.65571294 |
| 88 | BMX | 0.63633474 |
| 89 | CSNK1G1 | 0.63064647 |
| 90 | NEK1 | 0.62801174 |
| 91 | IKBKE | 0.62726185 |
| 92 | CDK12 | 0.60205411 |
| 93 | NEK6 | 0.59788555 |
| 94 | MAPK12 | 0.58371831 |
| 95 | GRK1 | 0.58143092 |
| 96 | PAK1 | 0.56359708 |
| 97 | CCNB1 | 0.56185863 |
| 98 | PIM1 | 0.54947354 |
| 99 | RPS6KB1 | 0.53668061 |
| 100 | PRKD1 | 0.52470972 |
| 101 | FYN | 0.51156048 |
| 102 | TTN | 0.50331995 |
| 103 | CSNK1G2 | 0.49854164 |
| 104 | MARK3 | 0.49292200 |
| 105 | PDK1 | 0.49192607 |
| 106 | PRKCZ | 0.46176868 |
| 107 | PBK | 0.45880733 |
| 108 | EEF2K | 0.45847041 |
| 109 | MAP2K2 | 0.45524234 |
| 110 | FGR | 0.45322070 |
| 111 | MARK2 | 0.45181589 |
| 112 | CDK11A | 0.42738417 |
| 113 | MAPKAPK2 | 0.42454510 |
| 114 | PLK1 | 0.41114536 |
| 115 | RPS6KB2 | 0.40936221 |
| 116 | CDK2 | 0.39955540 |
| 117 | BMPR1B | 0.39884139 |
| 118 | ABL1 | 0.39207971 |
| 119 | MAP3K8 | 0.38119473 |
| 120 | ZAP70 | 0.37810105 |
| 121 | INSR | 0.36755424 |
| 122 | MAPK11 | 0.36397894 |
| 123 | NME1 | 0.35734149 |
| 124 | CDK15 | 0.35270879 |
| 125 | CSNK2A1 | 0.35189753 |
| 126 | MTOR | 0.33299837 |
| 127 | CDK1 | 0.33281356 |
| 128 | CDK14 | 0.32708753 |
| 129 | PKN1 | 0.31937078 |
| 130 | AURKB | 0.31744405 |
| 131 | WEE1 | 0.31201674 |
| 132 | MAP3K5 | 0.31198042 |
| 133 | KSR2 | 0.30521410 |
| 134 | JAK2 | 0.30357076 |
| 135 | NEK9 | 0.30335235 |
| 136 | CDK18 | 0.29758517 |
| 137 | CSNK1D | 0.29201789 |
| 138 | NTRK2 | 0.28937060 |
| 139 | TRIM28 | 0.27650913 |
| 140 | PASK | 0.26592005 |
| 141 | EIF2AK2 | 0.26492861 |
| 142 | RPS6KA6 | 0.22994007 |
| 143 | UHMK1 | 0.22682859 |
| 144 | ATR | 0.22458402 |
| 145 | EGFR | 0.22434105 |
| 146 | CHEK2 | 0.21958447 |
| 147 | DYRK1B | 0.21103860 |
| 148 | PRKCG | 0.21099547 |
| 149 | CHUK | 0.20488975 |
| 150 | PRKCB | 0.20268398 |
| 151 | CDK4 | 0.19957639 |
| 152 | MAP3K2 | 0.19645117 |
| 153 | PRKCE | 0.19023753 |
| 154 | MAPK4 | 0.17870611 |
| 155 | PLK3 | 0.17588168 |
| 156 | GSK3B | 0.15901847 |
| 157 | ATM | 0.14435573 |
| 158 | IRAK1 | 0.13286975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.78241958 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.02286492 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.48934056 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.64357402 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.15938668 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.51032923 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.45301271 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.31063732 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02498381 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00478655 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 1.87730954 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82627501 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.81527117 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.80375565 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.76602345 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 1.72089679 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.68198007 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.58078345 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56328348 |
| 20 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.51910396 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.50453741 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.43450113 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.43066192 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34889175 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33871527 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32762803 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32084731 |
| 28 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31412377 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31207083 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28233908 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26962510 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.25021031 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22401477 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.19372270 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14663757 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14391621 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11029783 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10877958 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.09357926 |
| 40 | Prostate cancer_Homo sapiens_hsa05215 | 1.09025284 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08930182 |
| 42 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.08368043 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06892182 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01552873 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00993217 |
| 46 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.00675498 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.97388616 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95201969 |
| 49 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93285701 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.93246676 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91079912 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.89385610 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87292064 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85832722 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85030737 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84366561 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83408499 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82022184 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81704104 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81132125 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80678877 |
| 62 | RNA polymerase_Homo sapiens_hsa03020 | 0.79052543 |
| 63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76211426 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.74146339 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73800897 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73488349 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73253929 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72094907 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71808694 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.68906955 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.68580147 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65889052 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64308699 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63514943 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62931779 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.62311332 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62116858 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.59462521 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.59456591 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59364178 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59274289 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58717178 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.56934854 |
| 84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55734008 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54705701 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.54043063 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53533933 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52462872 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.52113456 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52097813 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50831749 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50522431 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.49787736 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49092091 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48451693 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47488378 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.47242221 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.46455930 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46120742 |
| 100 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46026875 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46026390 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45266758 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.45098383 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44305330 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.44029538 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41330599 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41122404 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40961982 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40405946 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38652544 |
| 111 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38559588 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37377274 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36987427 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36138013 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34781209 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33378566 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33281330 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32631923 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32531282 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31429373 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31164391 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.30910233 |
| 123 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.29260902 |
| 124 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29047168 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27922310 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27802850 |
| 127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26837083 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22909931 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.20960189 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20137049 |
| 131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.19430892 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.18624809 |
| 133 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18312027 |
| 134 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17894517 |
| 135 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.16745621 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16625662 |
| 137 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.16603214 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16305669 |
| 139 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.16251762 |
| 140 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.15728123 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15527796 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.14619509 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.13943624 |
| 144 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12964467 |
| 145 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12100086 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.10251188 |
| 147 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.10083328 |
| 148 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.09778316 |
| 149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.09105175 |

